Department of Medicine

Insulin in vials
May 11, 2017

EETs contribute to insulin sensitivity

Interventions that increase circulating levels of compounds called EETs may improve insulin sensitivity and treat hypertension.

By Leigh MacMillan
May 10, 2017

Scientists create unique disease ‘catalog’ linked to immune system gene variations

A study led by researchers at Vanderbilt University Medical Center (VUMC) and the University of Arizona College of Pharmacy has generated the first comprehensive catalog of diseases in a single population associated with variations in HLA genes that regulate the body’s immune system.

By Bill Snyder
May 4, 2017

New test rapidly identifies cause of blood infections

Last month, Vanderbilt Clinical Laboratories introduced rapid molecular diagnostic testing to more quickly identify microorganisms that may be causing a patient’s bloodstream infection, along with the organism’s susceptibility to drugs.

By Paul Govern
May 4, 2017

Lovly elected to American Society for Clinical Investigation

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology at Vanderbilt, has been elected to The American Society for Clinical Investigation (ASCI).

By VUMC News and Communications
Insulin in vials
May 3, 2017

Therapeutic targets for diabetes

Vanderbilt investigators have identified novel regulators of insulin-producing beta-cell proliferation and survival, suggesting new targets for the treatment of type 2 diabetes.

By Leigh MacMillan
April 27, 2017

Hudson to receive Protein Society’s Brändén Award

Vanderbilt University biochemist Billy Hudson, Ph.D., has been awarded the 2017 Carl Brändén Award by The Protein Society for exceptional contributions to science, education and service.

By Bill Snyder
April 27, 2017

Protein structure may aid in treating Alzheimer’s disease

A new protein structure may guide the development of Alzheimer's therapeutics.
By Leigh MacMillan
April 24, 2017

Vanderbilt’s Christine Lovly elected to American Society for Clinical Investigation

By VUMC News and Communications
April 20, 2017

Study examines new breast cancer drug combination

A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests a drug combination which includes a PDK1 protein blocker may be more effective for breast cancer that has become resistant to cyclin-dependent kinase (CDK4/6) targeted therapy.
By VUMC News and Communications
April 20, 2017

Ancient sea creature unlocks a mystery of how tissue developed

The dawn of the Animal Kingdom began with a collagen scaffold that enabled the organization of cells into tissues.
By Bill Snyder
April 17, 2017

In emergencies, insurance matters

Medicaid expansion under the Affordable Care Act provides patients with a greater choice of hospital facilities, Vanderbilt researchers have found.
By Paul Govern
April 13, 2017

Trial to test implantable device to ease gastroesophageal reflux

For more than a dozen years Buz Harrison, a Nashville-based media producer, has been plagued by gastroesophageal reflux disease (GERD).
By Bill Snyder
April 13, 2017

Clue to pulmonary hypertension

Vanderbilt investigators have studied the relationship between race, cardiometabolic traits and pulmonary hypertension.
By Bill Snyder